Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cutaneous receptors are a diverse group of **sensory receptors located in the skin** that detect and transmit information about various external stimuli to the nervous system. They include mechanoreceptors (such as Merkel nerve endings, Meissner’s corpuscles/tactile corpuscles, Ruffini endings/bulbous corpuscles, and Pacinian corpuscles), thermoreceptors for temperature changes, nociceptors for pain and itch sensations, and chemoreceptors for certain chemical stimuli[1][2][3][4]. These receptors are responsible for sensing modalities such as touch, pressure, vibration, temperature changes (heat/cold), and pain. Each type is specialized by structure and function—for example: - **Mechanoreceptors** respond to mechanical deformation like stretch or vibration. - Merkel nerve endings sense sustained touch/pressure. - Meissner’s corpuscles detect light touch/texture. - Ruffini endings sense skin stretch. - Pacinian corpuscles detect deep pressure/high-frequency vibration[1][6]. - **Thermoreceptors** respond to heat or cold[1][2]. - **Nociceptors** signal tissue damage or potential harm as pain[1]. These receptors are not single molecular targets but rather broad classes encompassing multiple distinct proteins/cell types. They play essential roles in somatosensation but are not considered therapeutic targets themselves; instead individual molecular components within these systems may be targeted. Because "Skin receptors" refers collectively to many different molecules rather than a specific protein/receptor entity—and because it is an anatomical/functional grouping rather than a canonical drug target—this entry should be marked as incorrect if used where a specific molecular target is required[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cutaneous receptor.